the present invention is concerned with improved synergistic compositions effective in the treatment of diabetes and / or hyperglycemia . in particular , the present invention is concerned with synergistic compositions comprising inulin preparations having a defined degree of polymerisation of below about 25 and sulfonylureas and / or a sulfonamide and / or derivatives and / or metabolites thereof used in the treatment of type - 2 diabetes meliitus . said compositions are also used for preventing the development of or ameliorating , side - effects or conditions in a subject treated with sulfonylurea and / or a sulfonamide compounds , said side - effects including hypoglycemia , gastrointestinal disturbances , fatigue , weight gain , and satiety .